Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
23 Jul 2025$IOVA Iovance Biotherapeutics soared nearly 27% as traders and institutions digested a flurry of analyst updates despite a sharp drop in average 12-month price targets from $22.14 to $13.43. The recent updates show a wide range of sentiment, with Chardan Capital maintaining a $25 target while UBS slashed its view to $2. This volatility reflects uncertainty around Iovance pipeline and cash runway but has pulled momentum traders into the name. The surge in volume to over 108 million shares, far above the 15 million average, indicates heavy speculative interest fueled by potential binary outcomes in the company cell therapy pipeline and price discovery in light of new targets.
$HUMA Humacyte jumped 19% after news broke that it sold its Symvess product to a military treatment facility, igniting optimism around its regenerative medicine potential. This contract highlights the company’s positioning for niche but high-need government healthcare opportunities, providing a credibility boost that smaller biotechs often struggle to secure.
$LUNR Intuitive Machines rallied 18.5%, continuing its 33% monthly uptrend, even as BofA lowered its price target to $10.50 from $16 while maintaining an underperform rating. The driver? Policy shifts that could ease regulations for lunar missions, potentially lowering launch costs and increasing launch frequency for LUNR lunar landers.
$DALN DallasNews Corporation surged over 17% after confirming it received an unsolicited, non-binding acquisition proposal from MNG Enterprises, topping Hearst’s prior offer. M&A activity is often a catalyst for sustained upside in small-cap names, and the competitive bidding signals market confidence in DALN’s strategic value and potential synergies under new ownership.
$TTGT TechTarget climbed 17% after posting its first-half results, sparking renewed interest in the digital media and lead generation player. Investors appear to be focusing on stability in its recurring revenue base and potential for margin expansion as digital marketing budgets recover.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
